October 06, 2026

Knee vibrations may signal cartilage damage

Machine-learning models distinguished healthy knees from those with osteoarthritis-related cartilage damage, but age and BMI performed as well as or better than the vibration-based models.

MDSpire News

September 28, 2026

FDA approves new treatment for FOP

Total new heterotopic ossification volume decreased with treatment and increased with placebo at week 24.

MDSpire News

September 23, 2026

Muscle recovery following knee arthroplasty

Investigators assessed changes in quadriceps and hamstring strength and flexibility through 12 months following total knee arthroplasty.

MDSpire News

September 15, 2026

Ipsilateral reference may reduce THA fluoroscopy

Operative-time–adjusted findings favored the ipsilateral technique, while absolute fluoroscopy time and radiation exposure remained similar between approaches.

MDSpire News

September 11, 2026

Robotic knee surgery put to the test

RACER-Knee compared Mako-assisted and conventional total knee replacement across 10 hospitals in Great Britain.

MDSpire News

September 04, 2026

Inside the hip osteoarthritis microbiome

Investigators compared intra-articular microbial profiles and predicted metabolic pathways in patients with hip osteoarthritis and nonarthritic controls.

MDSpire News

August 31, 2026

Nocturnal pain in elbow disorders may predict sleep quality

Prospective multicenter study found poorer sleep quality was associated with greater pain and functional disability across common elbow conditions.

MDSpire News

August 21, 2026

Sex-based differences in hip replacement outcomes

A systematic review of more than 2.3 million patients found that women and men had different patterns of postoperative complications and recovery, with age and implant strategy modifying observed differences.

MDSpire News

August 21, 2026

Does kinematic alignment better restore gait in CPAK type 1 TKA?

Overall knee kinematics were similar between alignment strategies, but subgroup findings pointed to more physiologic gait with kinematic alignment.

MDSpire News

August 20, 2026

FDA approves garetosmab for adults with FOP

In the phase 3 OPTIMA trial, the 10-mg/kg and 3-mg/kg doses reduced new heterotopic ossification lesions by 90% and 94%, respectively, compared with placebo at 56 weeks.

MDSpire News